The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Populations in major American cities have bounced back from pandemic-induced drops, with New York, Houston and Los Angeles ...

With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.